Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (421-430 of 544) with videos related to

Pageof 55
Sort By:
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
The Pediatric Infectious Disease Journal|October 1, 2011
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in CanadaOtto G Vanderkooi, David W Scheifele, Douglas Girgenti, et al.
American Journal of Hematology|February 21, 2009
Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout miceXuebin Qin, Weiguo Hu, Wenping Song, et al.
Vaccine|May 21, 2013
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodiesMonika Polewicz, Aleksandra Gracia, Srinivas Garlapati, et al.
BMC Infectious Diseases|November 17, 2012
Molecular characterization of rotavirus isolates from select Canadian pediatric hospitalsAndrew McDermid, Nicole Le Saux, Elsie Grudeski, et al.
Human Vaccines & Immunotherapeutics|July 7, 2022
Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018Khaled Alsager, Nirma Khatri Vadlamudi, Taj Jadavji, et al.
Clinical and Experimental Immunology|June 1, 2006
Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussisJ B Knight, Y Y Huang, S A Halperin, et al.
Vaccine|December 12, 2018
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trialA Cattapan, K Browne, D M Halperin, et al.
Vaccine|November 15, 2011
Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infectionTyler H T Brown, Jason David, Elizabeth Acosta-Ramirez, et al.
Cancer Research|January 22, 2011
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysisWeiguo Hu, Xiaowen Ge, Tao You, et al.
Pageof 55

Showing results (421-430 of 544) with videos related to

Sort By:
Pageof 55
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
The Pediatric Infectious Disease Journal|October 1, 2011
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in CanadaOtto G Vanderkooi, David W Scheifele, Douglas Girgenti, et al.
American Journal of Hematology|February 21, 2009
Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout miceXuebin Qin, Weiguo Hu, Wenping Song, et al.
Vaccine|May 21, 2013
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodiesMonika Polewicz, Aleksandra Gracia, Srinivas Garlapati, et al.
BMC Infectious Diseases|November 17, 2012
Molecular characterization of rotavirus isolates from select Canadian pediatric hospitalsAndrew McDermid, Nicole Le Saux, Elsie Grudeski, et al.
Human Vaccines & Immunotherapeutics|July 7, 2022
Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018Khaled Alsager, Nirma Khatri Vadlamudi, Taj Jadavji, et al.
Clinical and Experimental Immunology|June 1, 2006
Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussisJ B Knight, Y Y Huang, S A Halperin, et al.
Vaccine|December 12, 2018
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trialA Cattapan, K Browne, D M Halperin, et al.
Vaccine|November 15, 2011
Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infectionTyler H T Brown, Jason David, Elizabeth Acosta-Ramirez, et al.
Cancer Research|January 22, 2011
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysisWeiguo Hu, Xiaowen Ge, Tao You, et al.
Pageof 55